TCL Archive In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute June 21, 1996
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive House Labor-HHS-Ed/ Committee Concerned About Cut In Prevention, Construction Budget March 20, 1992
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014
